The treatment of HPV+ head and neck cell lines with JQ1, the inhibitor of the BRD4 (Bromodomain Containing 4) protein that recognizes the H3K27ac histone mark, is able to downregulate cancer-specific AS isoforms and eventually inhibits tumor cell proliferation. This evidence concerns the gene BRD4 and cancer.